While replacing Humira revenue figured significantly in AbbVies decision to acquire Allergan for $62 billion (the deal officially closed in May), the company was already long busy with preemptive preparations on the brand level, positioning a pair of newer medicines, Skyrizi (risankizumab) and Rinvoq (upadacitinib), approved last year for psoriasis and RA, respectively, to drive future growth and, combined, offset Humira losses (FDA has approved five generic versions of the tumor necrosis factor [TNF] inhibitor, though AbbVie has secured patent protection in the US that will prevent sales of Humira biosimilars until 2023
When a company picks which indication to push first, they are telling you where they have the most confidence
Chemical Makeup Molecular Formula: C 221 H 366 N 72 O 67 S Molecular Weight: 5136 g/mol Other Known Titles: (3E)-hex-3-enoylsomatoliberin Research and Clinical Studies Tesamorelin Peptide and Lipodystrophy Lipodystrophy models refer to abnormal or pathological fat distribution and metabolism
[cited 2023 June 22] 5
Conflict of interest Authors MG-E, GL, NO-S, OB, IK, RV, DK and MB were employed by Fecundis Lab
